These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 28090499)
1. Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma. Kim EY; Hyun KH; Park YL; Park CH; Yun JS Ann Surg Treat Res; 2017 Jan; 92(1):1-8. PubMed ID: 28090499 [TBL] [Abstract][Full Text] [Related]
2. Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer. Alzahrani AS; Mohamed G; Al Shammary A; Aldasouqi S; Abdal Salam S; Shoukri M J Endocrinol Invest; 2005 Jun; 28(6):540-6. PubMed ID: 16117196 [TBL] [Abstract][Full Text] [Related]
3. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? Mazzaferri EL; Kloos RT J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270 [TBL] [Abstract][Full Text] [Related]
4. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation. Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815 [TBL] [Abstract][Full Text] [Related]
5. Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma. Jeong GC; Song M; Park HJ; Min JJ; Bom HS; Cho SG; Park KS; Kang SR; Kim J; Song HC; Kwon SY Nucl Med Mol Imaging; 2016 Dec; 50(4):329-336. PubMed ID: 27994688 [TBL] [Abstract][Full Text] [Related]
6. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation. Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272 [TBL] [Abstract][Full Text] [Related]
7. Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine. Kashat L; Orlov S; Orlov D; Assi J; Salari F; Walfish PG Endocrine; 2016 Nov; 54(2):460-466. PubMed ID: 27189148 [TBL] [Abstract][Full Text] [Related]
8. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Torlontano M; Crocetti U; D'Aloiso L; Bonfitto N; Di Giorgio A; Modoni S; Valle G; Frusciante V; Bisceglia M; Filetti S; Schlumberger M; Trischitta V Eur J Endocrinol; 2003 Jan; 148(1):19-24. PubMed ID: 12534353 [TBL] [Abstract][Full Text] [Related]
9. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer. Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278 [TBL] [Abstract][Full Text] [Related]
10. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin? Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080 [TBL] [Abstract][Full Text] [Related]
12. Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation. Rosario PW; Mineiro Filho AF; Prates BS; Silva LC; Calsolari MR Thyroid; 2012 Nov; 22(11):1140-3. PubMed ID: 23050786 [TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment. Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265 [TBL] [Abstract][Full Text] [Related]
14. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882 [TBL] [Abstract][Full Text] [Related]
15. Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation. Park DJ; Lim JA; Kim TH; Choi HS; Ahn HY; Lee EK; Lee YJ; Kim KW; Park YJ; Yi KH; Cho BY Endocr J; 2012; 59(11):1021-30. PubMed ID: 22814366 [TBL] [Abstract][Full Text] [Related]
16. Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer. Mousa U; Yikilmaz AS; Nar A Clin Transl Oncol; 2017 Aug; 19(8):1028-1034. PubMed ID: 28258491 [TBL] [Abstract][Full Text] [Related]